Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination
Trading on The Nasdaq Capital Market under the ticker symbol “PURR”
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 11/29/16 | UPLOAD | SEC-generated letter |
|
4 | |
| 11/28/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/18/16 | S-1/A | General form of registration statement for all companies including face-amount certificate companies |
|
132 | |
| 11/16/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/14/16 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/10/16 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) |
|
   |
50 |
| 11/09/16 | 8-K | Current report filing |
|
12 | |
| 10/28/16 | S-1 | General form of registration statement for all companies including face-amount certificate companies |
|
86 | |
| 10/28/16 | 8-K | Current report filing |
|
4 | |
| 10/06/16 | 3 | Initial statement of beneficial ownership of securities |
|
1 |
